European Journal of Epidemiology

, Volume 15, Issue 4, pp 341–348 | Cite as

Relationship between lifestyle and serum lipid and lipoprotein levels in middle-aged Japanese men

  • Noriyuki Nakanishi
  • Koji Nakamura
  • Shinhachiro Ichikawa
  • Kenji Suzuki
  • Kozo Tatara


Cross-sectional associations between lifestyle factors [cigarette smoking, alcohol intake, overall obesity indicated by body mass index (BMI), eating breakfast, snacking between meals, considering nutritional balance, coffee drinking, physical exercise, and hours of work and sleep] and serum lipid and lipoprotein levels were examined in 1580 middle-aged Japanese men in Osaka, Japan. From stepwise regression analyses, significant correlates with low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and Log triglyceride levels were, in the order of relative importance: BMI, alcohol intake (negative), and age for LDL cholesterol level; BMI (negative), cigarette smoking (negative), alcohol intake, considering nutritional balance, and physical exercise for HDL cholesterol level; and BMI, cigarette smoking, working hours (negative), considering nutritional balance (negative), alcohol intake, and coffee drinking (negative) for Log triglyceride level. The cumulative percentages of variation for LDL cholesterol, HDL cholesterol and Log triglyceride levels were 4.2%, 15.4% and 14.7%, respectively. From stepwise regression analyses, excluding BMI as a factor in the model, snacking between meals emerged as a significant factor for LDL cholesterol level and HDL cholesterol level (negative). The cumulative percentage of variation for each serum lipid and lipoprotein level was decreased (1.5% for LDL cholesterol, 6.8% for HDL cholesterol, and 3.1% for Log triglyceride). These results suggest that BMI has the strongest association with serum lipid and lipoprotein levels and that good daily lifestyles may have an anti-atherogenic effect by altering serum lipid and lipoprotein levels in middle-aged Japanese men.

Japanese men Lifestyle Lipids Lipoproteins Middle age 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ueshima H. Changes in dietary habits, cardiovascular risk factors and mortality in Japan. (abstract). Acta Cardiol 1990; 45: 311–327.Google Scholar
  2. 2.
    Nutrition Division, Public Health Bureau, Ministry of Health and Welfare. Kokumin Eiyo No Genjyo (The National Nutrition Survey, 1990). Tokyo: Daiichi Shuppan, 1992 (In Japanese).Google Scholar
  3. 3.
    Ueshima H, Tatara K, Asakura S. Declining mortality from ischemic heart disease and changes in coronary risk factors in Japan, 1956–1980. Am J Epidemiol 1987; 125: 62–72.Google Scholar
  4. 4.
    Standing Medical Advisory Committee. Blood cholesterol testing. The cost-effectiveness of opportunistic cholesterol testing. London: Department of Health, 1990.Google Scholar
  5. 5.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Grundy SM, Chairman). The second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994; 89: 1329–1445.Google Scholar
  6. 6.
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.Google Scholar
  7. 7.
    National Cholesterol Education Program. Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Institutes of Health. Pub. No. 88–2925, 1988, p. 24.Google Scholar
  8. 8.
    Albrink MJ, Meigs JW, Man EB. Serum lipids, hypertension and coronary artery disease. Am J Med 1961; 31: 4–23.Google Scholar
  9. 9.
    Grundy SM, Mok HYI, Zech L, et al. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest 1979; 63: 1274–1283.Google Scholar
  10. 10.
    Gordon T, Fisher M, Ernst N, et al. Relation of diet to LDL cholesterol, VLDL cholesterol, and plasma total cholesterol and triglycerides in white adults: The Lipid Research Clinics Prevalence Study. Arteriosclerosis 1982; 2: 502–512.Google Scholar
  11. 11.
    Yano K, Reed DM, Curb JD, et al. Biological and dietary correlates of plasma lipids and lipoproteins among elderly Japanese men in Hawaii. Arteriosclerosis 1986; 6: 422–433.Google Scholar
  12. 12.
    Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993; 153: 1093–1103.Google Scholar
  13. 13.
    Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.Google Scholar
  14. 14.
    Berchtold P, Jorgans V, Finke C, et al. Epidemiology of obesity and hypertension. Int J Obesity 1981; 5(suppl 1): 1–7.Google Scholar
  15. 15.
    Blair D, Habicht JP, Sims EA, et al. Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 1984; 119: 526–540.Google Scholar
  16. 16.
    Hartz AJ, Rupley DC, Kalkhoff RD, et al. Relationship of obesity to diabetes: Influence of obesity level and body fat distribution. Prev Med 1983; 12: 351–357.Google Scholar
  17. 17.
    Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986; 6: 123–130.Google Scholar
  18. 18.
    Caggiula AW, Christakis G, Farrand M, et al. The Multiple Risk Factor Intervention Trial (MRFIT): IV. intervention on blood lipids. Prev Med 1981; 10: 443–475.Google Scholar
  19. 19.
    Gordon DJ, Salz KM, Roggenkamp KJ, et al. Dietary determinants of plasma cholesterol change in the recruitment phase of the Lipid Research Clinics Coronary Primary Prevention Trial. Arteriosclerosis 1982; 2: 537–548.Google Scholar
  20. 20.
    Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988; 319: 1173–1179.Google Scholar
  21. 21.
    Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205–211.Google Scholar
  22. 22.
    Criqui MH, Wallace RB, Heiss G, et al. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62(suppl IV): 70–76.Google Scholar
  23. 23.
    Phillips NR, Havel RJ, Kane JP. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides: Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis 1981; 1: 13–24.Google Scholar
  24. 24.
    Hegarty KM, Turgiss LE, Mulligan JJ, et al. Effects of cigarette smoking on high density lipoprotein phospholipids. Biochem Biophys Res Commun 1982; 104: 212–219.Google Scholar
  25. 25.
    Castelli WP, Doyle JT, Gordon T, et al. Alcohol and blood lipids. The Cooperative Lipoprotein Phenotyping Study. Lancet 1977; ii: 153–155.Google Scholar
  26. 26.
    Ernst N, Fisher M, Smith W, et al. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62(suppl IV): 41–52.Google Scholar
  27. 27.
    Frimpong NA, Lapp JA. Effects of moderate alcohol intake in fixed or variable amounts on concentration of serum lipids and liver enzymes in healthy young men. Am J Clin Nutr 1989; 50: 987–991.Google Scholar
  28. 28.
    Marmot MG, Rose G, Shipley MJ, et al. Alcohol and mortality: A U-shaped curve. Lancet 1981; i: 580–583.Google Scholar
  29. 29.
    Criqui MH. The roles of alcohol in the epidemiology of cardiovascular diseases. Acta Med Scand 1987; 717(suppl): 73–85.Google Scholar
  30. 30.
    Klatsky AL, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol 1990; 66: 1237–1242.Google Scholar
  31. 31.
    Criqui MH, Cowan LD, Tyroler HA, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: Results from the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987; 126: 629–637.Google Scholar
  32. 32.
    Suh I, Shaten BJ, Cutler JA, et al. Alcohol use and mortality from coronary heart disease: The role of high-density lipoprotein cholesterol. Ann Intern Med 1992; 116: 881–887.Google Scholar
  33. 33.
    Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523–1526.Google Scholar
  34. 34.
    Renaud SC, Beswick AD, Fehily AM, et al. Alcohol and platelet aggregation: The Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992; 55: 1012–1017.Google Scholar
  35. 35.
    Nikkila EA, Taskinen MR, Rehunen S, Harkonen M. Lipoprotein lipase activities in adipose tissue and skeletal muscle of runners: Relation to serum lipoproteins. Metabolism 1978; 27: 1661–1671.Google Scholar
  36. 36.
    Aro A, Teirilä J, Gref CG. Dose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee. Atherosclerosis 1990; 83: 257–261.Google Scholar
  37. 37.
    Bak AAA, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med 1989; 321: 1432–1437.Google Scholar
  38. 38.
    Stensvold I, Tverda A, Foss OP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40–42 years. J Clin Epidemiol 1989; 42: 877–884.Google Scholar
  39. 39.
    Wensten-Van der Woum MPME, Katan MB, Viani R, et al. Identify of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 1994; 35: 721–733.Google Scholar
  40. 40.
    Urgert R, Van der Weg G, Kosmeijer-Schuil TG, et al. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995; 43: 2167–2172.Google Scholar
  41. 41.
    Thelle DS, Arnesen E, Førde OH. The Tromsø Heart Study. Does coffee raise serum cholesterol? N Engl J Med 1983; 308: 1454–1457.Google Scholar
  42. 42.
    Williams PT, Wood PD, Vranizan KM, et al. Coffee intake and elevated cholesterol and apolipoproten B levels in men. JAMA 1985; 253: 1407–1411.Google Scholar
  43. 43.
    Phillips NR, Havel RJ, Kanel JP. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Atherosclerosis 1981; 1: 13–24.Google Scholar
  44. 44.
    Fisher M, Gordon T. The relation of drinking and smoking habits to diet: The Lipid Research Clinics Prevalence Study. Am J Clin Nutr 1985; 41: 623–630.Google Scholar
  45. 45.
    Jones BR, Barrett-Connor E, Criqui MH, et al. A community study of calorie and nutrient intake in drinkers and nondrinkers of alcohol. Am J Clin Nutr 1982; 35: 135–139.Google Scholar
  46. 46.
    Hillers VN, Massey LK. Interrelationships of moderate and high alcohol consumption with diet and health status. Am J Clin Nutr 1985; 41: 356–362.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Noriyuki Nakanishi
    • 1
  • Koji Nakamura
    • 2
  • Shinhachiro Ichikawa
    • 2
  • Kenji Suzuki
    • 3
  • Kozo Tatara
    • 1
  1. 1.Department of Public HealthOsaka University Medical SchoolJapan
  2. 2.Medical Office, Osaka Main OfficeTakenaka CorporationJapan
  3. 3.Japan Labor and Welfare AssociationJapan

Personalised recommendations